Don’t miss the latest developments in business and finance.

Serum Institute to invest $68 mn in UK vaccine-maker Oxford Biomedica

British cell therapy firm makes announcement.

Adar Poonawalla, CEO, Serum Institute
Adar Poonawalla, CEO, Serum Institute of India
Reuters Bengaluru
1 min read Last Updated : Sep 22 2021 | 12:38 PM IST
Vaccine producer Serum Institute of India will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the Covid-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said on Wednesday.

Topics :Serum InstituteAstraZenecaCoronavirus Vaccine